The effect of pulsed electromagnetic fields and dehydroepiandrosterone on viability and osteo-induction of human mesenchymal stem cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 1, 2015, Pages 31-40

  Kaivosoja, Emilia ^a,b   Sariola, Veikko ^a   Chen, Yan ^a   Konttinen, Yrjö T ^a,c,d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b AALTO UNIVERSITY   (Finland)

^c ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^d COXA Hospital for Joint Replacement ^*  (Finland)

Author keywords

Dehydroepiandrosterone; Mesenchymal stem cells; Osteoblastic; Osteogenic differentiation; Pulsed electromagnetic field; Viability

Indexed keywords

ELECTROMAGNETIC FIELDS; FLOWCHARTING; HYDROXYAPATITE; PHOSPHATASES; STEM CELLS;

CELL-BE; CELL/B.E; CELL/BE; DEHYDROEPIANDROSTERONE; HUMAN MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; OSTEOBLASTIC; OSTEOGENIC DIFFERENTIATION; PULSED ELECTROMAGNETIC FIELDS; VIABILITY;

CELL CULTURE;

ALKALINE PHOSPHATASE; ANDROSTANOLONE; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PRASTERONE; SMAD1 PROTEIN; TRANSCRIPTION FACTOR RUNX2; ASCORBIC ACID; BETA-GLYCEROPHOSPHORIC ACID; CHOLESTENONE 5ALPHA REDUCTASE; DEXAMETHASONE; GLYCEROPHOSPHATE; HYDROXYAPATITE;

ALP GENE; ARTICLE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DENSITY; CELL VIABILITY; COL1 GENE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; OC GENE; OP GENE; PULSED ELECTRIC FIELD; RUNX2 GENE; SAOS-2 CELL LINE; SMAD1 GENE; BONE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ELECTROMAGNETIC FIELD; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOBLAST; PATHOLOGY; PHYSIOLOGY; REGENERATION;

ASCORBIC ACID; BONE AND BONES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CHOLESTENONE 5 ALPHA-REDUCTASE; DEHYDROEPIANDROSTERONE; DEXAMETHASONE; DURAPATITE; ELECTROMAGNETIC FIELDS; GLYCEROPHOSPHATES; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; REGENERATION;

EID: 84920614470     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1612     Document Type: Article

References (40)

1. Aaron RK, Ciombor DM. 1996; Acceleration of experimental endochondral ossification by biophysical stimulation of the progenitor cell pool. J Orthop Res 14: 582-589.
2. Bassett CA, Pawluk RJ, Pilla AA. 1974; Acceleration of fracture repair by electromagnetic fields. A surgically noninvasive method. Ann NY Acad Sci 238: 242-262.
3. Bassett CAL, Mitchell SN, Gaston SR. 1982; Pulsing electromagnetic-field treatment in ununited fractures and failed arthrodeses. J Am Med Assoc 247: 623-628.
4. Bassett CAL, Schinkascani M. 1991; Long-term pulsed electromagnetic-field (PEMF) results in congenitalpseudoarthrosis. Calcified Tissue Int 49: 216-220.
5. Bovenberg SA, van Uum SH, Hermus AR. 2005; Dehydroepiandrosterone administration in humans: evidence based? Neth J Med 63: 300-304.
6. Carvalho RS, Schaffer JL, Gerstenfeld LC. 1998; Osteoblasts induce osteopontin expression in response to attachment on fibronectin: demonstration of a common role for integrin receptors in the signal transduction processes of cell attachment and mechanical stimulation. J Cell Biochem 70: 376-390.
7. Ciombor DM, Aaron RK. 1993; Influence of electromagnetic fields on endochondral bone formation. J Cell Biochem 52: 37-41.
8. Dallari D, Fini M, Giavaresi G, et al. 2009; Effects of pulsed electromagnetic stimulation on patients undergoing hip revision prostheses: a randomized prospective double-blind study. Bioelectromagnetics 30: 423-430.
9. Dimitriou R, Babis GC. 2007; Biomaterial osseointegration enhancement with biophysical stimulation. J Musculoskel Neuron Interact 7: 253-265.
10. Evans HC, Goa KL. 2003; Dutasteride. Drugs Aging 20: 906-916.
11. Fini M, Cadossi R, Canè V, et al. 2002; The effect of pulsed electromagnetic fields on the osteointegration of hydroxyapatite implants in cancellous bone: a morphologic and microstructural in vivo study. J Orthop Res 20: 756-763.
12. Griffin XL, Warner F, Costa M. 2008; The role of electromagnetic stimulation in the management of established non-union of long bone fractures: what is the evidence? Injury 39: 419-429.
13. Hammes A, Andreassen TK, Spoelgen R, et al. 2005; Role of endocytosis in cellular uptake of sex steroids. Cell 122: 751-762.
14. Hartkamp A, Geenen R, Godaert GL, et al. 2004; The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus. Arthritis Rheum 50: 3591-3595.
15. Heckman JD, Ingram AJ, Loyd RD, et al. 1981; Nonunion treatment with pulsed electromagnetic fields. Clin Orthop Relat Res 161: 58-66.
16. Hughes FJ, Aubin JE. 1998; Culture of cells of the osteoblast lineage. In Methods in Bone Biology, Arnett TR, Henderson B (eds). Chapman and Hall: London; 1-49.
17. Jansen JH, van der Jagt OP, Punt BJ, et al. 2010; Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study. BMC Musculoskel Disord 11: 188.
18. Kaivosoja E, Barreto G, Levón K, et al. 2011; Chemical and physical properties of regenerative medicine materials controlling stem cell fate. Ann Med doi: 10.3109/07853890.2011.573805
19. Khosla S, Amin S, Orwoll E. 2008; Osteoporosis in men. Endocr Rev 29: 441.
20. Malik AK, Khaldoyanidi S, Auci DL, et al. 2010; 5-Androstene-3β, 7β, 17β-triol (β-AET) slows thermal injury induced osteopenia in mice: relation to aging and osteoporosis. PLoS One 5: e13566.
21. Mammi GI, Rocchi R, Cadossi R, et al. 1993; The electrical stimulation of tibial osteotomies - double blind study. Clin Orthop Rel Res 288: 246-253.
22. Matsunaga S, Sakou T, Ijiri K. 1996; Osteogenesis by pulsing electromagnetic fields (PEMFs): optimum stimulation setting. In Vivo 10: 351-356.
23. McBeath R, Pirone DM, Nelson CM, et al. 2004; Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6: 483-495.
24. McCleary VL, Akers TK, Aasen GH. 1991; Low magnetic field effects on embryonic bone growth. Biomed Sci Instrum 27: 205-217.
25. Midura RJ, Ibiwoye MO, Powell KA, et al. 2005; Pulsed electromagnetic field treatments enhance the healing of fibular osteotomies. J Orthop Res 23: 1035-1046.
26. Miller WL. 2009; Androgen synthesis in adrenarche. Rev Endocr Metab Disord 10: 3-17.
27. Rodríguez Fernández JL, Ben-Ze'ev A. 1989; Regulation of fibronectin, integrin and cytoskeleton expression in differentiating adipocytes: inhibition by extracellular matrix and polylysine. Differentiation 42: 65-74.
28. Rubin CT, McLeod KJ, Lanyon LE. 1989; Prevention of osteoporosis by pulsed electromagnetic fields. J Bone Joint Surg Am 71: 411-417.
29. Schwartz Z, Fisher M, Lohmann CH, et al. 2009; Osteoprotegerin (OPG) production by cells in the osteoblast lineage is regulated by pulsed electromagnetic fields in cultures grown on calcium phosphate substrates. Ann Biomed Eng 37: 437-444.
30. Schwartz Z, Simon BJ, Duran MA, et al. 2008; Pulsed electromagnetic fields enhance BMP-2-dependent osteoblastic differentiation of human mesenchymal stem cells. J Orthop Res 26: 1250-1255.
31. Sillat T, Pöllänen R, Lopes JR, et al. 2009; Intracrine androgenic apparatus in human bone marrow stromal cells. J Cell Mol Med 13: 3296-3302.
32. Slemenda C, Hui SL, Longcope C, et al. 1987; Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest 80: 1261-1269.
33. Spiegelman BM, Ginty CA. 1983; Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell 35: 657-666.
34. Sun LY, Hsieh DK, Yu TC, et al. 2009; Effect of pulsed electromagnetic field on the proliferation and differentiation potential of human bone marrow mesenchymal stem cells. Bioelectromagnetics 30: 251-260.
35. Tabrah F, Hoffmeier M, Gilbert F Jr, et al. 1990; Bone density changes in osteoporosis-prone women exposed to pulsed electromagnetic fields (PEMFs). J Bone Miner Res 5: 437-442.
36. Thomas CH, Collier JH, Sfeir CS, et al. 2002; Engineering gene expression and protein synthesis by modulating nuclear shape. Proc Natl Acad Sci USA 99: 1972-1977.
37. Tian G, Mook RA Jr, Moss ML, et al. 1995; Mechanism of time-dependent inhibition of 5α-reductases by δ1-4-azasteroids: towards perfection of rates of time-dependent inhibition by using ligand-binding energies. Biochemistry 34: 13453-13459.
38. Tsai MT, Li WJ, Tuan RS, et al. 2009; Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res 27: 1169-1174.
39. von Muhlen D, Laughlin GA, Kritz-Silverstein D, et al. 2008; Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos Int 19: 699-707.
40. Wolf OT, Kirschbaum C. 1999; Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Rev 30: 264-288.